» Articles » PMID: 11478893

In Vitro Activation of Soluble Guanylyl Cyclase and Nitric Oxide Release: a Comparison of NO Donors and NO Mimetics

Overview
Journal Biochemistry
Specialty Biochemistry
Date 2001 Aug 2
PMID 11478893
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Nitric oxide (NO) performs a central role in biological systems, binding to the heme site of soluble guanylyl cyclase (sGC), leading to enzyme activation and elevation of intracellular levels of cGMP. Organic nitrates, in particular, nitroglycerin (GTN), are clinically important nitrovasodilators that function as NO-mimetics in biological systems. Comparison of sGC activation data with electrochemically measured rates of NO release for genuine NO donors, NONOates and nitrosothiols, yields an excellent correlation between the EC(50) for sGC activation and the rate constant for NO release, k(NO). However, activation of sGC by GTN and the nitrates has very different characteristics, including the requirement for specific added thiols, for example, cysteine. The reaction of GTN with cysteine in anaerobic solution yields NO slowly, and NO release, measured by chemiluminescence detection, is quenched by added metal ion chelator. The generation of NO under aerobic conditions is 100-fold slower than the anaerobic reaction. Furthermore, NO release from the reaction of GTN with cysteine in phosphate buffer is too slow to account for sGC activation by GTN/cysteine. The slow rate of the chemical reaction to release NO suggests that nitrates can activate sGC by an NO-independent mechanism. In contrast to the genuine NO donors, GTN behaves as a partial agonist with respect to sGC activation, but in the presence of the allosteric sGC activator, YC-1, GTN exhibits full agonist activity.

Citing Articles

Homogeneous single-label cGMP detection platform for the functional study of nitric oxide-sensitive (soluble) guanylyl cyclases and cGMP-specific phosphodiesterases.

Kopra K, Sharina I, Martin E, Harma H Sci Rep. 2020; 10(1):17469.

PMID: 33060787 PMC: 7562898. DOI: 10.1038/s41598-020-74611-x.


Structural insights into the mechanism of human soluble guanylate cyclase.

Kang Y, Liu R, Wu J, Chen L Nature. 2019; 574(7777):206-210.

PMID: 31514202 DOI: 10.1038/s41586-019-1584-6.


Pharmacological manipulation of cGMP and NO/cGMP in CNS drug discovery.

Hollas M, Ben Aissa M, Lee S, Gordon-Blake J, Thatcher G Nitric Oxide. 2018; 82:59-74.

PMID: 30394348 PMC: 7645969. DOI: 10.1016/j.niox.2018.10.006.


Soluble guanylyl cyclase is a critical regulator of migraine-associated pain.

Ben Aissa M, Tipton A, Bertels Z, Gandhi R, Moye L, Novack M Cephalalgia. 2017; 38(8):1471-1484.

PMID: 29022756 PMC: 5916516. DOI: 10.1177/0333102417737778.


Sub-Nanomolar Sensitivity of Nitric Oxide Mediated Regulation of cGMP and Vasomotor Reactivity in Vascular Smooth Muscle.

Held K, Dostmann W Front Pharmacol. 2012; 3:130.

PMID: 22807915 PMC: 3395022. DOI: 10.3389/fphar.2012.00130.